Concepedia

Author

Véronique Pascal

National Cancer Institute

Also Known As

V Pascal, V. Pascal, Veronique Pascal, Véronique Pascal, Véronique Pascal

45

Publications

830

Citations

14

H-Index

37

Concepts

All Affiliations

National Cancer InstituteFrederick National Laboratory for Cancer ResearchCenter for Cancer ResearchScience Applications International Corporation (United States)Inserm
VP

About

Véronique Pascal is an author at National Cancer Institute specializing in medicine, autoimmunity, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

298

2

Cell Biology

2

2

117

3

Blood Transplantation

1

1

14

4

Cellular Physiology

1

1

16

5

Cellular Therapies

1

1

14

Véronique Pascal

×

15

Publications

676

Citations

13

H-Index

YearCitations

Identification of Probabilistic Transcriptional Switches in the Ly49 Gene Cluster

Ali Saleh, Gareth E. Davies, Véronique Pascal,

Immunity

2004

111

Genetic Control of Variegated KIR Gene Expression: Polymorphisms of the Bi-Directional KIR3DL1 Promoter Are Associated with Distinct Frequencies of Gene Expression

Hongchuan Li, Véronique Pascal, Maureen P. Martin,

PLoS Genetics

2008

101

Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions

Véronique Pascal, N. Schleinitz, Corinne Brunet,

European Journal of Immunology

2004

74

Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools

Kasper Lamberth, Stine Louise Reedtz-Runge, Jonathan Simón,

Science Translational Medicine

2017

64

Detection of KIR3DS1 on the Cell Surface of Peripheral Blood NK Cells Facilitates Identification of a Novel Null Allele and Assessment of KIR3DS1 Expression during HIV-1 Infection

Véronique Pascal, Eriko Yamada, Maureen P. Martin,

The Journal of Immunology

2007

56

A Novel Developmental and Immunodeficiency Syndrome Associated With Intrauterine Growth Retardation and a Lack of Natural Killer Cells

Frédéric Bernard, Capucine Pïcard, Valérie Cormier‐Daire,

PEDIATRICS

2004

49

Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

Arne Kolstad, Tim Illidge, Nils Bolstad,

Blood Advances

2020

44

Balance between activating <scp>NKG</scp>2D, <scp>DNAM</scp>‐1, <scp>NK</scp>p44 and <scp>NK</scp>p46 and inhibitory <scp>CD</scp>94/<scp>NKG</scp>2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts

Natasja Nielsen, Véronique Pascal, Andreas E. R. Fasth,

Immunology

2014

42

Autoimmunity, spontaneous tumourigenesis, and IL‐15 insufficiency in mice with a targeted disruption of the tumour suppressor gene <i>Fus1</i>

A. A. Ivanova, Véronique Pascal, JM Ward,

The Journal of Pathology

2007

38

Hematopoiesis and Thymic Apoptosis Are Not Affected by the Loss of Cdk2

Cyril Berthet, María Cecilia Rodriguez‐Galán, Deborah L. Hodge,

Molecular and Cellular Biology

2007

26

Page 1